Nomura Holdings Inc Biogen Inc. Call Options Transaction History

Nomura Holdings Inc

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $2.65 Million - $3.35 Million	12,500 New	12,500 $2.7 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $3.54 Million - $4.22 Million	-18,900 Reduced 82.53%	4,000 $859,000
Q1 2022 May 18, 2022	SELL	$193.77 - $244.14 $271,278 - $341,796	-1,400 Reduced 5.76%	22,900 $4.92 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $5.13 Million - $6.59 Million	22,900 Added 1635.71%	24,300 $5.84 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $3.18 Million - $3.73 Million	-13,100 Reduced 90.34%	1,400 $392,000
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $1.29 Million - $1.53 Million	-5,000 Reduced 25.64%	14,500 $3.47 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $5.07 Million - $7.17 Million	-19,500 Reduced 50.0%	19,500 $5.35 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $5.07 Million - $7.17 Million	19,500 Added 100.0%	39,000 $11.6 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $1.54 Million - $1.72 Million	-5,000 Reduced 20.41%	19,500 $6.22 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $6.89 Million - $8.08 Million	24,500	24,500 $7.69 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.